WallStSmart

Ethos Technologies Inc. Class A Common Stock (LIFE)vsMarsh & McLennan Companies, Inc. (MRSH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Marsh & McLennan Companies, Inc. generates 6861% more annual revenue ($26.98B vs $387.61M). LIFE leads profitability with a 18.4% profit margin vs 15.4%. LIFE trades at a lower P/E of 8.6x. LIFE earns a higher WallStSmart Score of 66/100 (B-).

LIFE

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 8.3Quality: 5.0

MRSH

Buy

64

out of 100

Grade: C+

Growth: 6.0Profit: 8.5Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LIFEUndervalued (+80.7%)

Margin of Safety

+80.7%

Fair Value

$53.35

Current Price

$10.09

$43.26 discount

UndervaluedFair: $53.35Overvalued
MRSHSignificantly Overvalued (-28.9%)

Margin of Safety

-28.9%

Fair Value

$134.21

Current Price

$173.10

$38.89 premium

UndervaluedFair: $134.21Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIFE4 strengths · Avg: 9.3/10
P/E RatioValuation
8.6x10/10

Attractively priced relative to earnings

Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Return on EquityProfitability
21.0%9/10

Every $100 of equity generates 21 in profit

Operating MarginProfitability
22.2%8/10

Strong operational efficiency at 22.2%

MRSH4 strengths · Avg: 8.5/10
Market CapQuality
$85.18B9/10

Large-cap with strong market position

Return on EquityProfitability
29.3%9/10

Every $100 of equity generates 29 in profit

Operating MarginProfitability
25.4%8/10

Strong operational efficiency at 25.4%

Free Cash FlowQuality
$2.06B8/10

Generating 2.1B in free cash flow

Areas to Watch

LIFE2 concerns · Avg: 3.5/10
EPS GrowthGrowth
1.6%4/10

1.6% earnings growth

Market CapQuality
$618.69M3/10

Smaller company, higher risk/reward

MRSH1 concerns · Avg: 4.0/10
PEG RatioValuation
1.714/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : LIFE

The strongest argument for LIFE centers on P/E Ratio, Revenue Growth, Return on Equity. Profitability is solid with margins at 18.4% and operating margin at 22.2%. Revenue growth of 65.5% demonstrates continued momentum.

Bull Case : MRSH

The strongest argument for MRSH centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 15.4% and operating margin at 25.4%.

Bear Case : LIFE

The primary concerns for LIFE are EPS Growth, Market Cap.

Bear Case : MRSH

The primary concerns for MRSH are PEG Ratio.

Key Dynamics to Monitor

LIFE profiles as a growth stock while MRSH is a mature play — different risk/reward profiles.

LIFE is growing revenue faster at 65.5% — sustainability is the question.

MRSH generates stronger free cash flow (2.1B), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LIFE scores higher overall (66/100 vs 64/100), backed by strong 18.4% margins and 65.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Marsh & McLennan Companies, Inc.

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people globally. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?